[go: up one dir, main page]

KR900700457A - 4-아미노-3-아실퀴놀린 유도체 및 이의 위산 분비 억제제로서의 용도 - Google Patents

4-아미노-3-아실퀴놀린 유도체 및 이의 위산 분비 억제제로서의 용도

Info

Publication number
KR900700457A
KR900700457A KR1019890701954A KR890701954A KR900700457A KR 900700457 A KR900700457 A KR 900700457A KR 1019890701954 A KR1019890701954 A KR 1019890701954A KR 890701954 A KR890701954 A KR 890701954A KR 900700457 A KR900700457 A KR 900700457A
Authority
KR
South Korea
Prior art keywords
inhibitors
amino
gastric acid
acid secretion
acylquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019890701954A
Other languages
English (en)
Other versions
KR0159083B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR900700457A publication Critical patent/KR900700457A/ko
Application granted granted Critical
Publication of KR0159083B1 publication Critical patent/KR0159083B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019890701954A 1988-02-25 1989-02-20 4-아미노-3-아실퀴놀린 유도체 및 이의 위산분비 억제제로서의 용도 Expired - Fee Related KR0159083B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8804444 1988-02-25
GB888804444A GB8804444D0 (en) 1988-02-25 1988-02-25 Compounds
PCT/EP1989/000175 WO1989008104A1 (en) 1988-02-25 1989-02-20 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion

Publications (2)

Publication Number Publication Date
KR900700457A true KR900700457A (ko) 1990-08-13
KR0159083B1 KR0159083B1 (ko) 1998-12-01

Family

ID=10632376

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890701954A Expired - Fee Related KR0159083B1 (ko) 1988-02-25 1989-02-20 4-아미노-3-아실퀴놀린 유도체 및 이의 위산분비 억제제로서의 용도

Country Status (22)

Country Link
US (1) US5089504A (ko)
EP (1) EP0330485B1 (ko)
JP (1) JPH0774204B2 (ko)
KR (1) KR0159083B1 (ko)
CN (2) CN1027368C (ko)
AU (1) AU606508B2 (ko)
CA (1) CA1332839C (ko)
CZ (1) CZ398391A3 (ko)
DE (1) DE68906687T2 (ko)
DK (1) DK166623B1 (ko)
ES (1) ES2055037T3 (ko)
FI (1) FI93952C (ko)
GB (1) GB8804444D0 (ko)
HU (1) HU208814B (ko)
IE (1) IE63239B1 (ko)
IL (1) IL89346A (ko)
MY (1) MY105158A (ko)
NZ (1) NZ228098A (ko)
PT (1) PT89789B (ko)
WO (1) WO1989008104A1 (ko)
ZA (1) ZA891402B (ko)
ZW (1) ZW1989A1 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
EP0480052B1 (en) * 1990-03-28 1998-01-14 Otsuka Pharmaceutical Co., Ltd. Quinoline derivative, antiulcer drug containing the same, and production of said derivative
MA22401A1 (fr) * 1991-01-29 1992-10-01 Smithkline Beecham Intercredit Procede de preparation de sels de guinoleine
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
SE9302005D0 (sv) 1993-06-11 1993-06-11 Ab Astra New active compounds
EP1086094A1 (en) 1998-05-23 2001-03-28 Byk Gulden Lomberg Chemische Fabrik GmbH Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
HN2000000203A (es) 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CA2467652A1 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
CN106496119A (zh) * 2016-10-17 2017-03-15 江南大学 一种n‑苯基‑8‑氨基喹啉的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2652398A (en) * 1949-11-17 1953-09-15 Endo Products Inc N-substituted-2-amino (methyl) quinolines
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
ZA801526B (en) * 1979-03-26 1981-08-26 Robins Co Inc A H 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds

Also Published As

Publication number Publication date
IE890568L (en) 1989-08-25
PT89789A (pt) 1989-10-04
ZA891402B (en) 1990-09-26
CN1100414A (zh) 1995-03-22
DE68906687D1 (de) 1993-07-01
JPH02503318A (ja) 1990-10-11
EP0330485B1 (en) 1993-05-26
HU891463D0 (en) 1990-01-28
DK528889A (da) 1989-10-24
CZ398391A3 (en) 1994-05-18
FI93952C (fi) 1995-06-26
DK166623B1 (da) 1993-06-21
NZ228098A (en) 1990-10-26
IL89346A (en) 1994-01-25
HU208814B (en) 1994-01-28
AU3181989A (en) 1989-09-22
CN1035501A (zh) 1989-09-13
FI895048A0 (fi) 1989-10-24
HUT53086A (en) 1990-09-28
DK528889D0 (da) 1989-10-24
CN1027368C (zh) 1995-01-11
IE63239B1 (en) 1995-04-05
GB8804444D0 (en) 1988-03-23
CA1332839C (en) 1994-11-01
DE68906687T2 (de) 1993-12-02
EP0330485A1 (en) 1989-08-30
ES2055037T3 (es) 1994-08-16
WO1989008104A1 (en) 1989-09-08
MY105158A (en) 1994-08-30
ZW1989A1 (en) 1989-09-13
US5089504A (en) 1992-02-18
JPH0774204B2 (ja) 1995-08-09
PT89789B (pt) 1994-05-31
FI93952B (fi) 1995-03-15
AU606508B2 (en) 1991-02-07
KR0159083B1 (ko) 1998-12-01

Similar Documents

Publication Publication Date Title
KR900700457A (ko) 4-아미노-3-아실퀴놀린 유도체 및 이의 위산 분비 억제제로서의 용도
DK383581A (da) Aminosyrederivater deres fremtilling og anvendelse
EG18128A (en) Process for preparation of substituted thienoimidazole derivatives and their use as inhibitors of gastric acid secretion
FI895046A7 (fi) 4-amino-3-asyylikinoliinijohdannaiset ja niiden käyttö mahanesteiden e rittymisen estäjinä
EP0273689A3 (en) Derivatives of n-(2-alkyl-3-mercapto-glutaryl) alpha-amino acids and their use as collagenase inhibitors
DK346486D0 (da) Aminosalicylsyrederivater og farmaceutiske midler
KR880700673A (ko) 골손상 치료용방법 및 조성물
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
ZA891442B (en) Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
FI933376A7 (fi) 4-amino-3-asyylikinoliinijohdannaisten suolat ja niiden käyttö vatsaha ppoerityksen inhibiittoreina
FI893426L (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
DK162686D0 (da) Pseudopterosin og syntetisk derivater deraf og forbindelsernes anvendelse
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
AU7465487A (en) Benzimidazole derivatives and their use as gastric acid secretion inhibitors
DK713288A (da) Anvendelse af katakol-o-metyltransferase-inhibitorer og fysiologisk acceptable salte og estere deraf
NZ217322A (en) Toluidine derivatives and gastric acid inhibitor compositions
FI884960A7 (fi) 2-pyrimidinyyli-1-piperatsiini-johdannaisten käyttö
NO845148L (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater
NO176543C (no) Fortilsetningsmiddel og anvendelse av det i for til oppdrettsfisk
AU3494293A (en) Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
ZA929568B (en) 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion
DK318586A (da) Fremgangsmaade til fremstilling af acyloxybenzensulfonsyrer og saltederaf
DK335386D0 (da) Embonater af quinoloncarboxylsyrer og derivater deraf

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20010811

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20010811

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000